Quick Answer
INVO Fertility, Inc. reported Total Revenue of $6.53 million for fiscal year 2024.
INVO Fertility, Inc. — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $6.53M +116.3% |
$3.02M +267.4% |
$822.2K -80.2% |
$4.16M +301.1% |
$1.04M -29.9% |
$1.48M +199.4% |
| Revenue (ASC 606) | — | $3.02M +267.4% |
$822.2K -80.2% |
$4.16M +301.1% |
$1.04M | — |
| Net Income | -$9.10M -13.2% |
-$8.03M +26.2% |
-$10.89M -63.7% |
-$6.65M +20.3% |
-$8.35M -285.1% |
-$2.17M +29.5% |
| Diluted EPS | -$30.19 +55.2% |
-$67.37 -274.9% |
-$17.97 -2752.4% |
-$0.63 +58.6% |
-$1.52 -237.8% |
-$0.45 -2150.0% |
| Total Assets | $46.45M +151.0% |
$18.51M +351.0% |
$4.10M -60.8% |
$10.47M -4.4% |
$10.95M +509.7% |
$1.80M +131.0% |
| Cash and Equivalents | — | — | — | $5.68M -43.7% |
$10.10M +715.3% |
$1.24M +483.6% |
| Stockholders Equity | $12.75M +1327.8% |
$892.8K +191.3% |
-$977.6K -113.4% |
$7.31M +27.3% |
$5.74M +254.7% |
-$3.71M -36.3% |
| R&D Expense | $489.7K +195.1% |
$165.9K -69.5% |
$544.0K +151.4% |
$216.4K -45.7% |
$398.4K | $0.00 |
| Operating Income | -$8.13M -20.1% |
-$6.77M +36.3% |
-$10.63M -103.7% |
-$5.22M +5.4% |
-$5.51M -208.4% |
-$1.79M +32.1% |
| Gross Profit | — | — | $490.7K -87.8% |
$4.02M +323.3% |
$948.5K -29.2% |
$1.34M +231.8% |
| Shares Outstanding | 373,021 +79.6% |
207,711 -65.9% |
608,611 -94.9% |
11.93M +23.8% |
9.64M +97.3% |
4.88M -96.8% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $1.76M | +22.6% | -5.7% |
| Revenue (ASC 606) | September 30, 2024 | $1.43M | +47.0% | -22.0% |
| Net Income | September 30, 2025 | -$2.64M | -62.2% | +50.0% |
| Diluted EPS | September 30, 2025 | -$0.77 | +94.9% | +94.2% |
| Total Assets | September 30, 2025 | $18.83M | +10.7% | -2.5% |
| Cash and Equivalents | June 30, 2022 | $1.96M | -70.5% | -48.9% |
| Stockholders Equity | September 30, 2025 | $5.85M | +25184.6% | +122.3% |
| R&D Expense | March 31, 2025 | $265.7K | +5343.9% | +5343.9% |
| Operating Income | September 30, 2025 | -$1.64M | -25.8% | +45.3% |
| Gross Profit | March 31, 2023 | $275.5K | +182.1% | +118.3% |
| Shares Outstanding | September 30, 2025 | 5.42M | +38.9% | +555.0% |
- INVO Fertility, Inc. reported Total Revenue of $6.53 million for fiscal year 2024.
- INVO Fertility, Inc. showed an increase of +116.3% in Total Revenue compared to the prior fiscal year.
- INVO Fertility, Inc. reported Revenue (ASC 606) of $3.02 million for fiscal year 2023.
- INVO Fertility, Inc. showed an increase of +267.4% in Revenue (ASC 606) compared to the prior fiscal year.
- INVO Fertility, Inc. reported Net Income of -$9.10 million for fiscal year 2024.
- INVO Fertility, Inc. showed a decrease of -13.2% in Net Income compared to the prior fiscal year.
- INVO Fertility, Inc. reported Diluted EPS of $30.19 per share (loss) for fiscal year 2024.
- INVO Fertility, Inc. showed an increase of +55.2% in Diluted EPS compared to the prior fiscal year.
- INVO Fertility, Inc. reported Total Assets of $46.45 million for fiscal year 2024.
- INVO Fertility, Inc. showed an increase of +151.0% in Total Assets compared to the prior fiscal year.
- INVO Fertility, Inc. reported Cash and Equivalents of $5.68 million for fiscal year 2021.
- INVO Fertility, Inc. showed a decrease of -43.7% in Cash and Equivalents compared to the prior fiscal year.
- INVO Fertility, Inc. reported Stockholders Equity of $12.75 million for fiscal year 2024.
- INVO Fertility, Inc. showed an increase of +1327.8% in Stockholders Equity compared to the prior fiscal year.
- INVO Fertility, Inc. reported R&D Expense of $489.7 thousand for fiscal year 2024.
- INVO Fertility, Inc. showed an increase of +195.1% in R&D Expense compared to the prior fiscal year.
- INVO Fertility, Inc. reported Operating Income of -$8.13 million for fiscal year 2024.
- INVO Fertility, Inc. showed a decrease of -20.1% in Operating Income compared to the prior fiscal year.
- INVO Fertility, Inc. reported Gross Profit of $490.7 thousand for fiscal year 2022.
- INVO Fertility, Inc. showed a decrease of -87.8% in Gross Profit compared to the prior fiscal year.
- INVO Fertility, Inc. reported Shares Outstanding of 373.0 thousand shares for fiscal year 2024.
- INVO Fertility, Inc. showed an increase of +79.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: